Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial evaluating leriglitazo...
CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Novo Nordisk has reported interim Phase III FRONTIER4 extension data for denecimig, also known as Mim8, in people with h...
NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...
Innovative Molecules has dosed the first patient in its Phase 2a clinical trial evaluating adibelivir for recurrent geni...
Innovent Biologics has dosed the first patient in the Chinese pivotal Phase III TriadicMM-1 trial of IBI3003 for relapse...
FedEx has highlighted the need for more integrated, intelligent and sustainable pharmaceutical logistics networks in Asi...
Minghui Pharmaceutical has presented complete Phase I/II clinical data for MHB018A, a subcutaneous anti-IGF-1R antibody ...
CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...
Rznomics has presented interim Phase 1/2a clinical data for RZ-001, its RNA editing-based anticancer gene therapy for re...
MaaT Pharma has presented final Phase 3 data from the ARES pivotal trial evaluating MaaT013 in acute graft-versus-host d...
Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO), announced a strategic pa...
In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...
The project will modernize Lilly’s facilities in Carolina, generate over 1,100 new jobs across construction and op...
Expecto Health Science, an emerging Asia-Pacific Contract Research Organisation (CRO) led by a highly experienced leader...
The International Vaccine Institute (IVI) is partnering with SK bioscience of South Korea to conduct Phase III clinical ...
On account of World Hypopara Awareness Day on June 1st, VISEN Pharmaceuticals, a biotech company focused on developing a...
While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...
I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discovery, devel...
Gilead Sciences, Inc. on 15 Oct 2020 announced findings from multiple studies in Asian population that evaluated th...
